Evaluation of Efficacy, Safety, and Cognitive Profile of Amisulpride Per Se and Its Comparison with Olanzapine in Newly Diagnosed Schizophrenic Patients in an 8-Week, Double-Blind, Single-Centre, Prospective Clinical Trial

Table 2

Patient flow through study.

	Amisulpride	Olanzapine
Patients randomized	40	41
Completed	32 [80%]	32 [78.04%]
Premature withdrawal:	8 [20%]	9 [21.96%]
Lost to followup	1	1
Lack of efficacy	3	4
Adverse event	1	0
Unco-operative	1	2
Others	2	1